, ROS, reactive oxygen species
,
, CDDP
, H 2 DCFDA, 2?,7?-dichlorodihydrofluorescein diacetate; TrxR
,
, NEAA, nonessential amino acids; FBS, fetal bovine serum
s modified eagle's medium; BME, basal medium eagle; NMR, nuclear magnetic resonance; ESI-MS, electrospray ionization-mass spectrometry; RP-HPLC, reverse phase-high-performance liquid chromatography; DMSO-d 6 , deuterated dimethyl sulfoxide; MeOH-d 4 , deuterated methanol; ddH 2 O, ultrapure water; ICP-OES, inductively couple plasma-optical emission spectrometry, ICP-MS ,
,
, DTNB, vol.5, issue.2, p.5
, UPR, unfolded protein response
, , pp.arene Schiff-base
Bcl-2, B-cell lymphoma 2; Bcl-x L , B-cell lymphoma extra large; BAX, bcl-2-associated X protein ,
, CCAAT-enhancer-binding protein homologous protein; PERK, PKR-like ER kinase
inositol-requiring enzyme 1A; ATF6, activating transcription factor 6; eif2?, eukaryotic translation initiation factor 2A; HBSS, Hank's balanced salt solution ,
Tumor Resistance to Apoptosis, Int. J. Cancer, vol.124, pp.511-515, 2009. ,
DNA Methylation and Apoptosis Resistance in Cancer Cells, Cells, issue.2, pp.545-573, 2013. ,
Molecular Signals in Antiapoptotic Survival Pathways, Leukemia, vol.15, pp.21-34, 2001. ,
Apoptosis Defects and Chemotherapy Resistance: Molecular Interaction Maps and Networks, Oncogene, vol.23, pp.2934-2949, 2004. ,
, Oncogene, vol.22, pp.3138-3151, 2003.
Apoptosis Block as a Barrier to Effective Therapy in Non Small Cell Lung Cancer, World J. Clin. Oncol, vol.5, pp.588-594, 2014. ,
Survival Signalling and Apoptosis Resistance in Glioblastomas: Opportunities for Targeted Therapeutics, Mol. Cancer, p.135, 2010. ,
Clinical Outcomes and Correlates of TP53 Mutations and Cancer. Cold Spring Harbor Perspect, Biol, 1016. ,
Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma, Clin. Cancer Res, vol.15, pp.1645-1654, 2009. ,
p53 and bcl-2 Expression Correlates With Clinical Outcome in a Series of Node-Positive Breast Cancer Patients, J. Clin. Oncol, vol.14, pp.1604-1610, 1996. ,
Killing a Cancer: What are the Alternatives?, Nat. Rev. Cancer, vol.12, pp.411-424, 2012. ,
Cancer Drug Resistance: An Evolving Paradigm, Nat. Rev. Cancer, vol.13, pp.714-726, 2013. ,
Therapeutic Agents Triggering Nonapoptotic Cancer Cell Death, J. Med. Chem, vol.56, pp.4823-4839, 2013. ,
Cell Death and Endoplasmic Reticulum Stress: Disease Relevance and Therapeutic Opportunities, Nat. Rev. Drug Discovery, vol.7, pp.1013-1030, 2008. ,
Unfolded Protein Response in Cancer: The Physician's Perspective, J. Hematol. Oncol, 2008. ,
Endoplasmic Reticulum Stress and Cancer, J. Cancer Prev, vol.19, pp.75-88, 2014. ,
Nelfinavir and Other Protease Inhibitors in Cancer: Mechanisms Involved in Anticancer Activity, 2009. ,
Analysis of Nelfinavir-Induced Endoplasmic Reticulum Stress, Methods Enzymol, pp.491-127, 2011. ,
,
, Sorafenib/Regorafenib and Lapatinib Interact to Kill CNS Tumor Cells. J. Cell. Physiol, vol.230, pp.131-139, 2015.
, Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity Against Chronic Lymphocytic Leukemia. Cancer Res, vol.74, pp.2520-2532, 2014.
Auranofin Induces Apoptosis by ROS-Mediated ER Stress and Mitochondrial Dysfunction and Displayed Synergistic Lethality With Piperlongumine in gastric Cancer, Oncotarget, vol.6, pp.36505-36521, 2015. ,
Organoplatinum(II) Complexes Containing Bis(N-heterocyclic carbene) Ligands Selectively Target the Endoplasmic Reticulum and Induce Potent Photo-Toxicity, Chem. Commun, vol.49, pp.5423-5425, 2013. ,
Response Profiling Using Shotgun Proteomics Enables Global Metallodrug Mechanisms of Action To Be Established, vol.23, pp.1881-1890, 2017. ,
A Ruthenium-Containing Organometallic Compound Reduces Tumor Growth Through Induction of the Endoplasmic Reticulum Stress Gene CHOP, Cancer Res, vol.69, pp.5458-5466, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-02360367
Induction of Caspase 8 and Reactive Oxygen Species by Ruthenium-Derived Anticancer Compounds With Improved Water Solubility and Cytotoxicity, Biochem. Pharmacol, vol.84, pp.1428-1436, 2012. ,
Immunogenic Cell Death and DAMPs in Cancer Therapy, Nat. Rev. Cancer, vol.12, pp.860-875, 2012. ,
Multimodal Immunogenic Cancer Cell Death as a Consequence of Anticancer Cytotoxic Treatments, Cell Death Differ, vol.21, pp.39-49, 2014. ,
, Cell Death Induced by
, Endoplasmic Reticulum Stress, FEBS J, vol.283, 2016.
Connecting Endoplasmic Reticulum Stress to Autophagy by Unfolded Protein Response and Calcium, Cell Death Differ, vol.14, pp.1576-1582, 2007. ,
Endoplasmic Reticulum Stress Induces Ligand-Independent TNFR1-Mediated Necroptosis in L929 cells, Cell Death Dis, vol.6, p.1587, 2015. ,
Endoplasmic Reticulum Vacuolation and Unfolded Protein Response Leading to Paraptosis Like Cell Death in Cyclosporine A Treated Cancer Cervix Cells is Mediated by Cyclophilin B Inhibition, Biochim. Biophys. Acta, Mol. Cell Res, 1843. ,
Discovery and Investigation of Anticancer Ruthenium-Arene Schiff-Base Complexes via Water-Promoted Combinatorial Three-Component Assembly, J. Med. Chem, vol.57, issue.14, pp.6043-6059, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02360394
Structural Determinants of p53-Independence in Anticancer Ruthenium-Arene Schiff-Base Complexes, Mol. Pharmaceutics, vol.13, pp.2543-2554, 2016. ,
Structural Tuning of Organoruthenium Compounds Allows Oxidative Switch to Control ER Stress Pathways and Bypass Multidrug Resistance, Chem. Sci, vol.7, pp.4117-4124, 2016. ,
, 107: Partition Coefficient (n-octanol/water): Shake Flask Method, 1995.
,
Differential Expression of Sucrase-isomaltase in Clones Isolated from Early and Late Passages of the Cell line Caco-2-Evidence for Glucose-Dependent Negative Regulation, J. Cell Sci, vol.107, pp.213-225, 1994. ,
Evaluation of a Tetrazolium-based Semiautomated Colorimetric Assay: Assessment of Chemosensitivity Testing, Cancer Res, vol.47, pp.936-942, 1987. ,
Increased Accumulation of p53 Protein in Cisplatin-Resistant Ovarian Cell Lines, Int. J. Cancer, vol.55, pp.678-684, 1993. ,
Acquired Alkylating Drug Resistanc of a Human Ovarian Carcinoma Cell Line is Unaffected by Altered Levels of Pro-and Anti-Apoptotic Proteins, Oncogene, vol.19, pp.141-150, 2000. ,
, , p.53
, Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan, Clin. Cancer Res, vol.10, pp.2158-2167, 2004.
Resistance of Colon Cancer Cells to Long-term 5-fluorouracil Exposure is Correlated to the Relative Level of Bcl-2 and Bcl-X(L) in Addition to Bax and p53 Status, Int. J. Cancer, vol.98, pp.498-504, 2002. ,
Jacks, T. p53-Dependent and Independent Expression of p21 During Cell Growth, Differentiation, and DNA Damage, Genes Dev, vol.9, pp.935-944, 1995. ,
Anticancer Activity of Metal Complexes: Involvement of Redox Processes, Antioxid. Redox Signaling, vol.15, pp.1085-1127, 2011. ,
Effect of Metal Complexes on Thioredoxin Reductase and the Regulation of Mitochondrial Permeability Conditions, Ann. N. Y. Acad. Sci, pp.348-354, 1030. ,
Chemical Biology of Anticancer Gold(III) and Gold(I) Gomplexes, Chem. Soc. Rev, vol.44, pp.8786-8801, 2015. ,
,
, Inhibition of Thioredoxin Reductase but Not of Glutathione Reductase by the Major Classes of Alkylating and Platinum-Containing Anticancer Compounds, Free Radical Biol. Med, pp.39-696, 2005.
The Unfolded Protein Response: Controlling Cell Fate Decisions Under ER stress and Beyond, Nat. Rev. Mol. Cell Biol, vol.13, pp.89-102, 2012. ,
Signal Integration in the Endoplasmic Reticulum Unfolded Protein Response, Nat. Rev. Mol. Cell Biol, vol.8, pp.519-529, 2007. ,
Roles of CHOP(GADD153) in ,
, Endoplasmic Reticulum Stress, Cell Death Differ, vol.11, pp.381-389, 2004.